{"ticker": {"uuid": "218c1ec9-eee9-4f4a-b896-94338fcfccd9", "symbol": "OSUR", "name": "OraSure Technologies Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "OraSure Technologies stock holds steady as diagnostics business targets growth", "summary": "OraSure Technologies (OSUR) is a Nasdaq-listed diagnostics and life-sciences company focusing on rapid infectious disease testing and molecular solutions. The company's business model combines consumables-driven testing with a growing molecular solutions segment, catering to both", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/orasure-technologies-stock-holds-steady-as-diagnostics-business-targets/69734271", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T17:42:01", "published_display": "09 Jul 2026 17:42", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies updates highlight diagnostics focus amid shifting health trends", "summary": "OraSure Technologies is focusing on its diagnostics and sampling portfolio, adapting to evolving demand for infectious-disease and at-home testing. The company, known for its rapid tests like OraQuick, aims to retain customers and launch new products as pandemic-driven demand nor", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/orasure-technologies-updates-highlight-diagnostics-focus-amid-shifting/69679279", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T11:09:13", "published_display": "03 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 OraSure Technologies Inc For: 30 June By Investing.com", "summary": "This article reports on the filing of Form 4 by OraSure Technologies Inc for the period ending June 30. Form 4 is a document that must be filed with the SEC whenever there is a material change in the holdings of company insiders. The article indicates that OraSure Technologies In", "url": "https://ca.investing.com/news/stock-market-news/form-4-orasure-technologies-inc-for-30-june-93CH-4714598", "source_name": "Investing.com Canada", "published_at": "2026-07-01T04:40:27", "published_display": "01 Jul 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) director takes 3,666-share stock grant in lieu of cash", "summary": "OraSure Technologies director Steven Kyle Boyd received a grant of 3,666 restricted shares of common stock, valued at $4.4325 per share, in lieu of cash director fees. This transaction, processed under the company's Stock Award Plan, immediately vested and increased Boyd's direct", "url": "https://www.stocktitan.net/sec-filings/OSUR/form-4-orasure-technologies-inc-insider-trading-activity-6aec2247dfd1.html", "source_name": "Stock Titan", "published_at": "2026-07-01T03:40:44", "published_display": "01 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSUR - Orasure Technologies Inc Latest SEC Filings", "summary": "This article provides detailed financial data and performance metrics for Orasure Technologies Inc (OSUR) as of June 30. It includes information on market capitalization, sales, income, various ratios, insider and institutional ownership, and stock performance over different peri", "url": "https://finviz.com/stock?t=OSUR&p=m&ty=lf&page=22", "source_name": "Finviz", "published_at": "2026-07-01T03:40:44", "published_display": "01 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of OraSure Technologies, Inc. \u2013 MUN:EP3", "summary": "The article focuses on the enterprise value to EBIT forward of OraSure Technologies, Inc. (MUN:EP3). It provides a high-level overview of the company's financial data on TradingView, listing it under Health Technology and Medical Specialties on the Munich Stock Exchange. The page", "url": "https://www.tradingview.com/symbols/MUN-EP3/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T22:39:25", "published_display": "29 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OraSure Technologies, Inc. \u2013 NASDAQ:OSUR", "summary": "This article provides a financial overview of OraSure Technologies, Inc. (NASDAQ: OSUR), focusing on its forward price-to-earnings ratio. It seems to be a placeholder or a stub page from a financial data provider, as it primarily lists navigation and platform features rather than", "url": "https://www.tradingview.com/symbols/NASDAQ-OSUR/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T05:14:07", "published_display": "29 Jun 2026 05:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OraSure Technologies, Inc. \u2013 NASDAQ:OSUR", "summary": "The article presents the \"Price to book forward\" financial metric for OraSure Technologies, Inc. (NASDAQ: OSUR). It is a brief data point provided by TradingView, indicating a specific financial value for the company within a given period.", "url": "https://www.tradingview.com/symbols/NASDAQ-OSUR/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T11:09:38", "published_display": "28 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OraSure Technologies, Inc. \u2013 LSX:881351", "summary": "This page from TradingView provides financial information for OraSure Technologies, Inc. (LSX:881351), specifically focusing on its price-to-book forward ratio. The content indicates that the market is currently closed and shows no recent trades for the company.", "url": "https://www.tradingview.com/symbols/LSX-881351/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T10:40:53", "published_display": "28 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of OraSure Technologies, Inc. \u2013 LSX:881351", "summary": "The article focuses on the \"Price to sales forward\" metric for OraSure Technologies, Inc. (LSX:881351) as of June 27, 2026. It appears to be a financial data snippet from a larger platform, indicating the company's valuation based on its forward sales. No specific financial figur", "url": "https://www.tradingview.com/symbols/LSX-881351/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:39:52", "published_display": "27 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of OraSure Technologies, Inc. \u2013 NASDAQ:OSUR", "summary": "The article displays the \"Price to sales forward\" metric for OraSure Technologies, Inc. (NASDAQ: OSUR) within the TradingView platform. It shows the period, value, change, and percentage change for this financial metric, indicating that the market was closed with no trades at the", "url": "https://www.tradingview.com/symbols/NASDAQ-OSUR/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T19:41:02", "published_display": "26 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OraSure Technologies, Inc. \u2013 LSX:881351", "summary": "The article focuses on the \"Price to earnings forward\" metric for OraSure Technologies, Inc. (LSX:881351) as listed on the Lang & Schwarz Exchange. It appears to be a financial data page from TradingView, indicating that the market was closed at the time of viewing. The content p", "url": "https://www.tradingview.com/symbols/LSX-881351/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T10:40:20", "published_display": "26 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Over 4.9% - Quarterly Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPYjU1ZzV0T1pnTlFGclYtcmd1bldmRjBRbVdabzJndWFzSEJ0UWUwWUVEY0R0WjlRaDIxRGhHdU1tNFFGWEVxNkpJdVlJMDJHSUFQVmhzQjl4cDVibFBhLXFBQWNrTkdzT001WFlhQ2ZveXBpSkJWc3NrYWdPSml3ZzZ2MkdfbHM1RG1PT0wtLTlpQkJqUkszU0l6S082Zm1JSEN2SGJaVk9sTXNqRWdfTDJMS2ZvTkF6anBqUXJDb2N6dGdDcFhHRGlaREU?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Pressured: Testing Support After Recent Decline - Sector ETF Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPMWppd21IOHQxSFM5QTNjQkgwdlItOXNNSkRkRUROODNTU0c4VWNWbi1TOURwbERKRjlmQU1wZkQ1LWRkdFJPZFJMQ0NpanhBQlpPLWN2Vm0tWlNfVUotYVdMUW5kbEtKS3Q3VjZxdU5pQzdFc0xZTTlJNEx5alBDQVhoTS1DT0JWWS1UeV9wNEJndDR6WUl3NGJ0dllQb3lzank0SFhBOUZGVmVqWndZ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of OraSure Technologies Inc (OSUR), detailing its price momentum, support and resistance levels, and various technical indicators. As of June 17, 2026, the stock has a price momentum score of 9.48, and its technical indicators and moving", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/technical", "source_name": "TradingKey", "published_at": "2026-06-17T18:10:32", "published_display": "17 Jun 2026 18:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for OraSure Technologies Inc (OSUR), detailing its current earnings forecast score, analyst ratings, and price targets. The company ranks 66 out of 203 in the Healthcare Equipment & Supplies industry with an average price target of $4.50", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T16:09:58", "published_display": "17 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for OraSure Technologies Inc (OSUR), categorizing its revenue by business segments and geographic regions. The company's main revenue streams come from Net product and services in HIV, Microbiome, and HCV, with the United States ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T15:09:58", "published_display": "17 Jun 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical dividend and stock split information for OraSure Technologies Inc (OSUR). It indicates that the company has distributed a total of 0.00 USD in dividends over the past five years and contains no data for historical stock splits. The article also pr", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-16T16:39:56", "published_display": "16 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSUR: At-Home STI Testing Expansion Will Drive Bullish Long-Term Outlook", "summary": "OraSure Technologies' (OSUR) analyst price target remains at $4.75, with its fair value unchanged despite slight adjustments to discount rate, profit margin, and future P/E assumptions. Key news includes FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit to expand at-home S", "url": "https://simplywall.st/community/narratives/us/healthcare/nasdaq-osur/orasure-technologies/hgrc9ti2-next-generation-diagnostics-will-transform-preventive-healthcare-z09d/updates/19-orasure-technologies-analyst-price-target-remains-at-dollar475", "source_name": "Simply Wall Street", "published_at": "2026-06-14T22:09:59", "published_display": "14 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Holds Steady Near Support as Volume Remains Subdued - Modified Schiff", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPMzFEd2FabXRPNFBYeXRzOUxlMTJjQm9aUm5kaU1waFpBX3ZIM0xZTE1pX1lTeEE4SmpqS0tnZWdNSzJ1aXcybFlNOWZLM3F4MTJoc3BRUnk0alpiZnBaei1Ub19BQTdZMW56S0JLYTJKLWE3ekREMDRjdGpDZm1ES0xsZk12MkhQNVRRd0x4YkxsU0NheFJYVHZZaHItT0E3RFpOM0hhdlBSSm1GcWZXYXpUQUx0RWJwSUUwNDR3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient\u2011Friendly Access to Testing for Sexually Transmitted Infections", "summary": "OraSure Technologies, Inc. announced FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit, allowing at-home self-collection of urine samples for STI testing. This kit integrates with Roche's cobas\u00ae molecular diagnostic systems to detect Chlamydia trachomatis, Neisseria gonorr", "url": "https://www.globenewswire.com/news-release/2026/06/11/3310399/11732/en/orasure-technologies-inc-announces-fda-clearance-that-expands-patient-friendly-access-to-testing-for-sexually-transmitted-infections.html", "source_name": "GlobeNewswire", "published_at": "2026-06-12T09:09:59", "published_display": "12 Jun 2026 09:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure gets FDA nod for at-home STI urine collection kit By Investing.com", "summary": "OraSure Technologies Inc. received FDA clearance for its Colli-Pee Dx Urine Collection Kit, enabling at-home STI sample collection for use with Roche's diagnostic tests. This development aims to increase accessibility and convenience for patients, contributing to OraSure's stock ", "url": "https://m.au.investing.com/news/stock-market-news/orasure-gets-fda-nod-for-athome-sti-urine-collection-kit-93CH-4482659?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-12T08:10:11", "published_display": "12 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure gets FDA nod for at-home STI urine collection kit", "summary": "OraSure Technologies Inc. has received FDA clearance for its Colli-Pee Dx Urine Collection Kit, allowing at-home sample collection for Roche's sexually transmitted infection tests. This development makes STI testing more accessible and convenient for patients. Despite the positiv", "url": "https://www.investing.com/news/company-news/orasure-gets-fda-nod-for-athome-sti-urine-collection-kit-93CH-4737357", "source_name": "Investing.com", "published_at": "2026-06-11T20:40:57", "published_display": "11 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure receives FDA clearance for home urine collection kit for STIs", "summary": "OraSure Technologies Inc., based in Bethlehem, has announced that its subsidiary DNA Genotek Inc. received FDA clearance for its Colli-Pee\u2022Dx Urine Collection Kit. This kit enables convenient at-home self-collection of first-void urine for STI testing, supporting various Roche di", "url": "https://lvb.com/orasure-fda-clearance-home-urine-kit-stis-bethlehem/", "source_name": "Lehigh Valley Business", "published_at": "2026-06-11T18:40:42", "published_display": "11 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Says FDA Clears At-Home Urine Collection Kit for STI Testing", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orasure-technologies-says-fda-clears-131035246.html", "source_name": "MT Newswires", "published_at": "2026-06-11T13:10:35+00:00", "published_display": "11 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (NASDAQ: OSUR) wins FDA clearance for Colli-Pee Dx at-home urine collection kit", "summary": "OraSure Technologies (NASDAQ: OSUR) has received FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit, developed by subsidiary DNA Genotek Inc. This kit is designed for at-home self-collection of first-void urine and is compatible with Roche Molecular Systems tests for severa", "url": "https://www.stocktitan.net/sec-filings/OSUR/8-k-orasure-technologies-inc-reports-material-event-79e2577914a1.html", "source_name": "Stock Titan", "published_at": "2026-06-11T12:40:42", "published_display": "11 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure secures FDA clearance for product seen as key to future growth", "summary": "OraSure Technologies (NASDAQ: OSUR) has received FDA clearance for its Colli-Pee kit, an at-home urine collection device used for detecting sexually transmitted infections in conjunction with Roche's molecular diagnostic systems. This clearance is seen as crucial for the Bethlehe", "url": "https://www.wfmz.com/news/area/lehighvalley/lehigh-county/bethlehem-area/orasure-secures-fda-clearance-for-product-seen-as-key-to-future-growth/article_822d1ff8-f89b-41af-8ae9-f0b39517bbfb.html", "source_name": "WFMZ.com", "published_at": "2026-06-11T12:40:42", "published_display": "11 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA clears at-home urine kit that lets labs test for 4 STIs by mail", "summary": "OraSure Technologies announced FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit, which allows at-home, first-void urine self-collection for testing of four common sexually transmitted infections (STIs) in conjunction with Roche's cobas\u00ae molecular diagnostic systems. This ", "url": "https://www.stocktitan.net/news/OSUR/ora-sure-technologies-inc-announces-fda-clearance-that-expands-x2hyrqpiub08.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:40:42", "published_display": "11 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure stock jumps on FDA clearance for at-home STI kit", "summary": "OraSure Technologies Inc. (NASDAQ:OSUR) shares jumped over 4% after receiving FDA clearance for its at-home urine collection kit for sexually transmitted infection (STI) testing. The kit, Colli-Pee Dx Urine Collection Kit, combines with Roche's molecular lab testing equipment to ", "url": "https://www.investing.com/news/stock-market-news/orasure-stock-jumps-on-fda-clearance-for-athome-sti-kit-93CH-4737577", "source_name": "Investing.com", "published_at": "2026-06-11T09:24:00", "published_display": "11 Jun 2026 09:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Slips 3.1% as Stock Tests Key Support Level - Leading Diagonal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMEpBX2xDUWRRcGc0MlN2c2gtSmVja3RNS1pPM3FiclFpSndDbDBBNWlPMHN3amZIOTQxMGNyc0dNcExweG5YWnAzNW1PeWdQdTl5MkJWM1RtbER4SDV1TGNiZzlySjg0SjFMbXdJR05UWkdPVHlzYTlUU0lacmxpcTBBdEhybTVkQVg1ekN5TVh5Y0pQcG9OUjE4WUtDOHY5cVBCaU9QZ0o?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Posts Modest Gain Amid Stabilization Near Support - Force Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNQ193OUx6T2FMLVZfUDg2dnI3ZnFGQlNYNXlRel9MOTlKMUVhNUwwZ1F3MGVJcnlzUWdYLWNXbmhVRTUxZEQtNGJrUDMtQnRNaE1vMnVwam5EeTZJSlh2d3d5Qm1uZllWMlJlMUJydC1XMV9OQ0NFS0EtNVZ5NjVWWTBCSHc1bFNFZmNEMTk5YnZnajJiTXJsMkk1QlNnQm1hV3MzdTM1N1Bac2JrMy1OTVJoOUFWeDlwSEJCdnRtRkRUUQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Gains 3.68% as Stock Approaches Key Resistance Level - Volume Breakout Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQOHNVTGRDTURlQWZFbHlNZ1IxYWZxMkhWY0Z1OEJBQVhYVHZWV0tEaFdSVmNCSXprTDVNVGstV2phcjcwY0dGWHliMXp6dUp5SUptdi1Zenh2ejVrTm9XZWpYNFBTQW51bDYtTDdoam9lWmY3UGt1Zkx3Q0ZOQ1dFbTAzMmFTTVgyaWNWQTB5bkN5MmRXcE9KdDVpTTBMenJhS21HZjJiald1eC1rZkN1SjN5Z2JFTmg2Mnc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Independent Director Acquires 195% More Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNU1VIMFdxMGFqRHpsUmpGNktCcVFSTnpCeGRkaXFTWHNXc041VGdJNXFjTEZ3M2xjX2JySHktUDQ1ZENDTmF5VlBkMlZtMzQ4WVU4UnkwZHktWTF0bVQxYkthRExKWmQ2aTB6aFJVT3FwOTU5NFhyVmpWVTh1WUhhY3dRVUd1TXh0V2VWZnRXZnl3ZVd3Q3FwWHFmclNIbERGMEdDRjhTNl84bU9aUHZ1ZFJVUC1DZw?oc=5", "source_name": "Market source", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) director buys 75,000 shares in market trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQc21tbkFpZkZXQ0NUUnRKLTZPUkVLOWFJaHBjZXhsSFJ0V2tCbmtXRkdHUzVta2xtakEwcXB5eVVZUFBOTkYwMHNVd0lIbGFUa3BpZENVclNXenltNVhaM2ZfT0dIVUVrMHo0Wkp0akgtcVNpYmh4TzZLbEpXSHRwUHhlZTBMUmxwdWZWSkF2bWZYMGMzNXk3ZmNuZTNfT1N2VWlqOWtselpocG9xQnppa1gyNGpmTkpJR0E?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure director Steven Boyd purchases $224,750 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxORndiUzM3YU1LZkp6WDBLZFpqbkYzaFVWVlJ5Rjk4SDQzZVotdlFJQUFBcGxRdDEzcGNfZlpUMzVHdHhxNHVhdTRZb2pyX2hLcWgyYzBJODRrUVpwbms3U1BHZk13dkdzQXhXVDBvLVpTQWE3M2x2TUFzVHdQd1BKbHVuWlRlT0NENS12Y0EzQjUtVHFKOENWM1BrTVB0YzVRbThxamdwNUlrclZ3UFZ1MUsxT21PRnhZNkVn?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/2d8c17e4-439d-3096-a9ed-621227ab7a82/orasure-technologies%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-07T12:30:00+00:00", "published_display": "07 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/27cb5c03-d8df-31b9-98b8-d095fda665ca/orasure-technologies-q1.html", "source_name": "MarketBeat", "published_at": "2026-05-07T03:06:38+00:00", "published_display": "07 May 2026 03:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure (OSUR) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/00baaff7-6020-3afa-b23e-986e07384ef9/orasure-%28osur%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-06T22:47:39+00:00", "published_display": "06 May 2026 22:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/orasure-q1-earnings-snapshot-213307242.html", "source_name": "Associated Press", "published_at": "2026-05-06T21:33:07+00:00", "published_display": "06 May 2026 21:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Announces First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNeGNwMzFqOWphWU5ncVpLSkc3VXVUXzhVYk4zUndnV1JCaG1hYTcyakUxWGpCR3Q5V2hHWTYwV1RydXU0VzFLdThCXzdrM0JrRDEyU1BQOEJwWWpXZUdyUUVyVGNjZ1RmZjdwbmx0MS1Vc0FJWDgxemhpaXQ1WmNBOEg3RWM0d29XLVRCSGZWQ2FYUl9BV2Q4LWMzU0RWSFdUYkZGS0JvMlZtQjV1MllmN25OaE1zaVVscnBMVUM5b2tMVlpG?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why OraSure Technologies (OSUR) Is Back in the Spotlight as Sale Pressure Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNelRtekF3N2Jad09GVnMtMnh4V0E3bUVpdXoyZ1RXMEQ1dVNaX1VZLTZPZ2k3NHpyckNFVHhzM3ljZXpkWkJxSTFGU05aUnl6VjVYSDFOaVJYbGVGNTcybmlzdXR4UXYtY0VfdkVEdVB4TXJFUWt4RmlvLXRab3hidlRGVXhYcExCNG9wZU9zYXpFZm1tMF8xbndtbDd0QlFt?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Altai Capital presses OraSure to sell and give it board seats, letter says", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNOWk4TEd4ZTRKcHhVZUE3NkFiNEFiUnNlek5kOWJ2V0tnbUpGc1pJcnhnNG4zQXFSR25Oam5FNnBFMUtVbUhsRE1aNFBBS1lLOG1uSFVYLS1nNGZ2YzN2Ym1HMWp4a1JIN1Y0T3NSTFNZZlIwbzJtZERxSjMtcGFLcFJVTVBZTG41R3M4QmlKUXhDcnlhbUliTktic2VIX0lmamlfSHdvOVhuOHRpQlFRdTFycERQUVZ4bTg1TmhDSkt1eTZlQnhpOW1LSEpqcTQ3MVZ6aEZtVlhTMGNSdjJOYQ?oc=5", "source_name": "Reuters", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Former VA head departs OraSure board", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOd0Z1a1RfakpCSXJwUDBkeW1neEo0X24xY0ZqTU9FWEtYbDFWNWduU1JjNnpMR013OE5sc1ZUc19jZ2YxeDlpd1JreW9VazVpZF9Bc3M1YTdBMV9kWHo4Yy1yZHUwOGdZVE5IMU5HczJPcFNBR05pTVNVWGhwbk1lY1dITmlXQU5zeFE2ZEdEZnlxZlNqazVvcEFFOWo0SDBTTGtpeW1BalhzUldDbkxqWlA2cGxMc0JOWVViRnhHT2JfWUZoRHJweVBn?oc=5", "source_name": "WFMZ.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Altai Capital lays groundwork for board fight at OraSure Technologies, sources say", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPQWlwakRvRmh0cTJHRXQybFhGQjd1SmRyMkF1bUYxMWhTT0RxRlhXbXVXS1hRd3Z4Q1NYQkJiWHh6MUl1c0FkNzMxQzNtbUZya0hqQjkwNXF4bkF2UTdUMnE2X1Z1S01SQUh1TjYyQWxqQkdrWU94cElBSkZGUzZ1eENvZjhIYnNJaTBXYjluN1gycDhTUmxXWUFwQTZQa0toQU96eXhlMlNLWG5ZaHFoaTM1LWNmZ2pFR3VROWpBeXNkMUdLNTFDQlRn?oc=5", "source_name": "Reuters", "published_at": "2025-09-09T07:00:00+00:00", "published_display": "09 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOemdiR1d1UEhMNE1DNzhmNVBpVlA3N2loQVg5dUFQaG5QNGtvSjk5MWdtZzNoWDJRTnIxRlhqZ3hXWkNHbl9RZHBlQTJqYTd4S2RoOG1EVlNLRnhRQ2kwOEFCMGs5S0lHZnRwcVVna0JoY3lHNlZEb3pHampmcHR3M2NfTDREd0VpOEUwYWRpSjI5bnJHMG5laXdadk9UNEcycUhtVWJFalltYjJOUkJyYWthdVh3VkQwX2FuTzduYURJaWJTSWtxSlJGaUxoOW01MWx6VnJiNEpZRXQ5WjZvVEg2RQ?oc=5", "source_name": "Reuters", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies, Inc. (NASDAQ:OSUR) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-08T07:00:00+00:00", "published_display": "08 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies received takeover bid from industry entrepreneur, sources say", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOVDY2eFJ1aER0SExrMllzOWJMS0ZUbXExSktkVEt6a3M0WmtGMW51U1psbWtsWE8zNGpFbWFhcjFfTzJ3MEhLSWs0N25Zb2swb0g0TThRUHNHM0RZRzV1c3FEc0lEZU9RNENoYkhKVjNPX1N2TXJBaUxld0NQdGUtUC0zdE0yQUJrdWJMeHdwaFNqeF83c2ZTV0s1Wk1MOE1DLWFpOWYxUVF2LXFFWmRkWGZaY0lYNkhGQzRpa0NFQkFLQ2hiM3BHSEhlZTc?oc=5", "source_name": "Reuters", "published_at": "2025-07-14T07:00:00+00:00", "published_display": "14 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orasure Tech (OSUR) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE4xejlIeUFnTThER0ZZbmZDX2Q0RWRiVjZlVDdVanViQjlfbFJnb3ZyeWd1eXBadU1pdjFJejZrRTBiSzRnSmkzdi1BMElOT1V5MWVr?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:31:43+00:00", "published_display": "25 Apr 2025 01:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies - OSUR - Stock Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE53dHZ5RlpxRHViLXhmQkdaZFRFdU1XMmg2Y25tRktUWDZvTHZHdDhrWWJVRmljNGVfb1lINGItNndETUhmVzl2MDJwMzBUck11?oc=5", "source_name": "The Motley Fool", "published_at": "2021-09-15T20:40:07+00:00", "published_display": "15 Sep 2021 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "OraSure Technologies stock holds steady as diagnostics business targets growth", "summary": "OraSure Technologies (OSUR) is a Nasdaq-listed diagnostics and life-sciences company focusing on rapid infectious disease testing and molecular solutions. The company's business model combines consumables-driven testing with a growing molecular solutions segment, catering to both", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/orasure-technologies-stock-holds-steady-as-diagnostics-business-targets/69734271", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T17:42:01", "published_display": "09 Jul 2026 17:42", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies updates highlight diagnostics focus amid shifting health trends", "summary": "OraSure Technologies is focusing on its diagnostics and sampling portfolio, adapting to evolving demand for infectious-disease and at-home testing. The company, known for its rapid tests like OraQuick, aims to retain customers and launch new products as pandemic-driven demand nor", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/orasure-technologies-updates-highlight-diagnostics-focus-amid-shifting/69679279", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T11:09:13", "published_display": "03 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 OraSure Technologies Inc For: 30 June By Investing.com", "summary": "This article reports on the filing of Form 4 by OraSure Technologies Inc for the period ending June 30. Form 4 is a document that must be filed with the SEC whenever there is a material change in the holdings of company insiders. The article indicates that OraSure Technologies In", "url": "https://ca.investing.com/news/stock-market-news/form-4-orasure-technologies-inc-for-30-june-93CH-4714598", "source_name": "Investing.com Canada", "published_at": "2026-07-01T04:40:27", "published_display": "01 Jul 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) director takes 3,666-share stock grant in lieu of cash", "summary": "OraSure Technologies director Steven Kyle Boyd received a grant of 3,666 restricted shares of common stock, valued at $4.4325 per share, in lieu of cash director fees. This transaction, processed under the company's Stock Award Plan, immediately vested and increased Boyd's direct", "url": "https://www.stocktitan.net/sec-filings/OSUR/form-4-orasure-technologies-inc-insider-trading-activity-6aec2247dfd1.html", "source_name": "Stock Titan", "published_at": "2026-07-01T03:40:44", "published_display": "01 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSUR - Orasure Technologies Inc Latest SEC Filings", "summary": "This article provides detailed financial data and performance metrics for Orasure Technologies Inc (OSUR) as of June 30. It includes information on market capitalization, sales, income, various ratios, insider and institutional ownership, and stock performance over different peri", "url": "https://finviz.com/stock?t=OSUR&p=m&ty=lf&page=22", "source_name": "Finviz", "published_at": "2026-07-01T03:40:44", "published_display": "01 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of OraSure Technologies, Inc. \u2013 MUN:EP3", "summary": "The article focuses on the enterprise value to EBIT forward of OraSure Technologies, Inc. (MUN:EP3). It provides a high-level overview of the company's financial data on TradingView, listing it under Health Technology and Medical Specialties on the Munich Stock Exchange. The page", "url": "https://www.tradingview.com/symbols/MUN-EP3/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T22:39:25", "published_display": "29 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OraSure Technologies, Inc. \u2013 NASDAQ:OSUR", "summary": "This article provides a financial overview of OraSure Technologies, Inc. (NASDAQ: OSUR), focusing on its forward price-to-earnings ratio. It seems to be a placeholder or a stub page from a financial data provider, as it primarily lists navigation and platform features rather than", "url": "https://www.tradingview.com/symbols/NASDAQ-OSUR/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T05:14:07", "published_display": "29 Jun 2026 05:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OraSure Technologies, Inc. \u2013 NASDAQ:OSUR", "summary": "The article presents the \"Price to book forward\" financial metric for OraSure Technologies, Inc. (NASDAQ: OSUR). It is a brief data point provided by TradingView, indicating a specific financial value for the company within a given period.", "url": "https://www.tradingview.com/symbols/NASDAQ-OSUR/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T11:09:38", "published_display": "28 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OraSure Technologies, Inc. \u2013 LSX:881351", "summary": "This page from TradingView provides financial information for OraSure Technologies, Inc. (LSX:881351), specifically focusing on its price-to-book forward ratio. The content indicates that the market is currently closed and shows no recent trades for the company.", "url": "https://www.tradingview.com/symbols/LSX-881351/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T10:40:53", "published_display": "28 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of OraSure Technologies, Inc. \u2013 LSX:881351", "summary": "The article focuses on the \"Price to sales forward\" metric for OraSure Technologies, Inc. (LSX:881351) as of June 27, 2026. It appears to be a financial data snippet from a larger platform, indicating the company's valuation based on its forward sales. No specific financial figur", "url": "https://www.tradingview.com/symbols/LSX-881351/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:39:52", "published_display": "27 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of OraSure Technologies, Inc. \u2013 NASDAQ:OSUR", "summary": "The article displays the \"Price to sales forward\" metric for OraSure Technologies, Inc. (NASDAQ: OSUR) within the TradingView platform. It shows the period, value, change, and percentage change for this financial metric, indicating that the market was closed with no trades at the", "url": "https://www.tradingview.com/symbols/NASDAQ-OSUR/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T19:41:02", "published_display": "26 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OraSure Technologies, Inc. \u2013 LSX:881351", "summary": "The article focuses on the \"Price to earnings forward\" metric for OraSure Technologies, Inc. (LSX:881351) as listed on the Lang & Schwarz Exchange. It appears to be a financial data page from TradingView, indicating that the market was closed at the time of viewing. The content p", "url": "https://www.tradingview.com/symbols/LSX-881351/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T10:40:20", "published_display": "26 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Over 4.9% - Quarterly Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPYjU1ZzV0T1pnTlFGclYtcmd1bldmRjBRbVdabzJndWFzSEJ0UWUwWUVEY0R0WjlRaDIxRGhHdU1tNFFGWEVxNkpJdVlJMDJHSUFQVmhzQjl4cDVibFBhLXFBQWNrTkdzT001WFlhQ2ZveXBpSkJWc3NrYWdPSml3ZzZ2MkdfbHM1RG1PT0wtLTlpQkJqUkszU0l6S082Zm1JSEN2SGJaVk9sTXNqRWdfTDJMS2ZvTkF6anBqUXJDb2N6dGdDcFhHRGlaREU?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Pressured: Testing Support After Recent Decline - Sector ETF Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPMWppd21IOHQxSFM5QTNjQkgwdlItOXNNSkRkRUROODNTU0c4VWNWbi1TOURwbERKRjlmQU1wZkQ1LWRkdFJPZFJMQ0NpanhBQlpPLWN2Vm0tWlNfVUotYVdMUW5kbEtKS3Q3VjZxdU5pQzdFc0xZTTlJNEx5alBDQVhoTS1DT0JWWS1UeV9wNEJndDR6WUl3NGJ0dllQb3lzank0SFhBOUZGVmVqWndZ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of OraSure Technologies Inc (OSUR), detailing its price momentum, support and resistance levels, and various technical indicators. As of June 17, 2026, the stock has a price momentum score of 9.48, and its technical indicators and moving", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/technical", "source_name": "TradingKey", "published_at": "2026-06-17T18:10:32", "published_display": "17 Jun 2026 18:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for OraSure Technologies Inc (OSUR), detailing its current earnings forecast score, analyst ratings, and price targets. The company ranks 66 out of 203 in the Healthcare Equipment & Supplies industry with an average price target of $4.50", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T16:09:58", "published_display": "17 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for OraSure Technologies Inc (OSUR), categorizing its revenue by business segments and geographic regions. The company's main revenue streams come from Net product and services in HIV, Microbiome, and HCV, with the United States ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T15:09:58", "published_display": "17 Jun 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Inc (OSUR) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical dividend and stock split information for OraSure Technologies Inc (OSUR). It indicates that the company has distributed a total of 0.00 USD in dividends over the past five years and contains no data for historical stock splits. The article also pr", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-osur/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-16T16:39:56", "published_display": "16 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSUR: At-Home STI Testing Expansion Will Drive Bullish Long-Term Outlook", "summary": "OraSure Technologies' (OSUR) analyst price target remains at $4.75, with its fair value unchanged despite slight adjustments to discount rate, profit margin, and future P/E assumptions. Key news includes FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit to expand at-home S", "url": "https://simplywall.st/community/narratives/us/healthcare/nasdaq-osur/orasure-technologies/hgrc9ti2-next-generation-diagnostics-will-transform-preventive-healthcare-z09d/updates/19-orasure-technologies-analyst-price-target-remains-at-dollar475", "source_name": "Simply Wall Street", "published_at": "2026-06-14T22:09:59", "published_display": "14 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Holds Steady Near Support as Volume Remains Subdued - Modified Schiff", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPMzFEd2FabXRPNFBYeXRzOUxlMTJjQm9aUm5kaU1waFpBX3ZIM0xZTE1pX1lTeEE4SmpqS0tnZWdNSzJ1aXcybFlNOWZLM3F4MTJoc3BRUnk0alpiZnBaei1Ub19BQTdZMW56S0JLYTJKLWE3ekREMDRjdGpDZm1ES0xsZk12MkhQNVRRd0x4YkxsU0NheFJYVHZZaHItT0E3RFpOM0hhdlBSSm1GcWZXYXpUQUx0RWJwSUUwNDR3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient\u2011Friendly Access to Testing for Sexually Transmitted Infections", "summary": "OraSure Technologies, Inc. announced FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit, allowing at-home self-collection of urine samples for STI testing. This kit integrates with Roche's cobas\u00ae molecular diagnostic systems to detect Chlamydia trachomatis, Neisseria gonorr", "url": "https://www.globenewswire.com/news-release/2026/06/11/3310399/11732/en/orasure-technologies-inc-announces-fda-clearance-that-expands-patient-friendly-access-to-testing-for-sexually-transmitted-infections.html", "source_name": "GlobeNewswire", "published_at": "2026-06-12T09:09:59", "published_display": "12 Jun 2026 09:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure gets FDA nod for at-home STI urine collection kit By Investing.com", "summary": "OraSure Technologies Inc. received FDA clearance for its Colli-Pee Dx Urine Collection Kit, enabling at-home STI sample collection for use with Roche's diagnostic tests. This development aims to increase accessibility and convenience for patients, contributing to OraSure's stock ", "url": "https://m.au.investing.com/news/stock-market-news/orasure-gets-fda-nod-for-athome-sti-urine-collection-kit-93CH-4482659?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-12T08:10:11", "published_display": "12 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure gets FDA nod for at-home STI urine collection kit", "summary": "OraSure Technologies Inc. has received FDA clearance for its Colli-Pee Dx Urine Collection Kit, allowing at-home sample collection for Roche's sexually transmitted infection tests. This development makes STI testing more accessible and convenient for patients. Despite the positiv", "url": "https://www.investing.com/news/company-news/orasure-gets-fda-nod-for-athome-sti-urine-collection-kit-93CH-4737357", "source_name": "Investing.com", "published_at": "2026-06-11T20:40:57", "published_display": "11 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure receives FDA clearance for home urine collection kit for STIs", "summary": "OraSure Technologies Inc., based in Bethlehem, has announced that its subsidiary DNA Genotek Inc. received FDA clearance for its Colli-Pee\u2022Dx Urine Collection Kit. This kit enables convenient at-home self-collection of first-void urine for STI testing, supporting various Roche di", "url": "https://lvb.com/orasure-fda-clearance-home-urine-kit-stis-bethlehem/", "source_name": "Lehigh Valley Business", "published_at": "2026-06-11T18:40:42", "published_display": "11 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Says FDA Clears At-Home Urine Collection Kit for STI Testing", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/orasure-technologies-says-fda-clears-131035246.html", "source_name": "MT Newswires", "published_at": "2026-06-11T13:10:35+00:00", "published_display": "11 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (NASDAQ: OSUR) wins FDA clearance for Colli-Pee Dx at-home urine collection kit", "summary": "OraSure Technologies (NASDAQ: OSUR) has received FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit, developed by subsidiary DNA Genotek Inc. This kit is designed for at-home self-collection of first-void urine and is compatible with Roche Molecular Systems tests for severa", "url": "https://www.stocktitan.net/sec-filings/OSUR/8-k-orasure-technologies-inc-reports-material-event-79e2577914a1.html", "source_name": "Stock Titan", "published_at": "2026-06-11T12:40:42", "published_display": "11 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure secures FDA clearance for product seen as key to future growth", "summary": "OraSure Technologies (NASDAQ: OSUR) has received FDA clearance for its Colli-Pee kit, an at-home urine collection device used for detecting sexually transmitted infections in conjunction with Roche's molecular diagnostic systems. This clearance is seen as crucial for the Bethlehe", "url": "https://www.wfmz.com/news/area/lehighvalley/lehigh-county/bethlehem-area/orasure-secures-fda-clearance-for-product-seen-as-key-to-future-growth/article_822d1ff8-f89b-41af-8ae9-f0b39517bbfb.html", "source_name": "WFMZ.com", "published_at": "2026-06-11T12:40:42", "published_display": "11 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA clears at-home urine kit that lets labs test for 4 STIs by mail", "summary": "OraSure Technologies announced FDA clearance for its Colli-Pee\u2122\u2022Dx Urine Collection Kit, which allows at-home, first-void urine self-collection for testing of four common sexually transmitted infections (STIs) in conjunction with Roche's cobas\u00ae molecular diagnostic systems. This ", "url": "https://www.stocktitan.net/news/OSUR/ora-sure-technologies-inc-announces-fda-clearance-that-expands-x2hyrqpiub08.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:40:42", "published_display": "11 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure stock jumps on FDA clearance for at-home STI kit", "summary": "OraSure Technologies Inc. (NASDAQ:OSUR) shares jumped over 4% after receiving FDA clearance for its at-home urine collection kit for sexually transmitted infection (STI) testing. The kit, Colli-Pee Dx Urine Collection Kit, combines with Roche's molecular lab testing equipment to ", "url": "https://www.investing.com/news/stock-market-news/orasure-stock-jumps-on-fda-clearance-for-athome-sti-kit-93CH-4737577", "source_name": "Investing.com", "published_at": "2026-06-11T09:24:00", "published_display": "11 Jun 2026 09:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Slips 3.1% as Stock Tests Key Support Level - Leading Diagonal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMEpBX2xDUWRRcGc0MlN2c2gtSmVja3RNS1pPM3FiclFpSndDbDBBNWlPMHN3amZIOTQxMGNyc0dNcExweG5YWnAzNW1PeWdQdTl5MkJWM1RtbER4SDV1TGNiZzlySjg0SjFMbXdJR05UWkdPVHlzYTlUU0lacmxpcTBBdEhybTVkQVg1ekN5TVh5Y0pQcG9OUjE4WUtDOHY5cVBCaU9QZ0o?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Posts Modest Gain Amid Stabilization Near Support - Force Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNQ193OUx6T2FMLVZfUDg2dnI3ZnFGQlNYNXlRel9MOTlKMUVhNUwwZ1F3MGVJcnlzUWdYLWNXbmhVRTUxZEQtNGJrUDMtQnRNaE1vMnVwam5EeTZJSlh2d3d5Qm1uZllWMlJlMUJydC1XMV9OQ0NFS0EtNVZ5NjVWWTBCSHc1bFNFZmNEMTk5YnZnajJiTXJsMkk1QlNnQm1hV3MzdTM1N1Bac2JrMy1OTVJoOUFWeDlwSEJCdnRtRkRUUQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) Gains 3.68% as Stock Approaches Key Resistance Level - Volume Breakout Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQOHNVTGRDTURlQWZFbHlNZ1IxYWZxMkhWY0Z1OEJBQVhYVHZWV0tEaFdSVmNCSXprTDVNVGstV2phcjcwY0dGWHliMXp6dUp5SUptdi1Zenh2ejVrTm9XZWpYNFBTQW51bDYtTDdoam9lWmY3UGt1Zkx3Q0ZOQ1dFbTAzMmFTTVgyaWNWQTB5bkN5MmRXcE9KdDVpTTBMenJhS21HZjJiald1eC1rZkN1SjN5Z2JFTmg2Mnc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Independent Director Acquires 195% More Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNU1VIMFdxMGFqRHpsUmpGNktCcVFSTnpCeGRkaXFTWHNXc041VGdJNXFjTEZ3M2xjX2JySHktUDQ1ZENDTmF5VlBkMlZtMzQ4WVU4UnkwZHktWTF0bVQxYkthRExKWmQ2aTB6aFJVT3FwOTU5NFhyVmpWVTh1WUhhY3dRVUd1TXh0V2VWZnRXZnl3ZVd3Q3FwWHFmclNIbERGMEdDRjhTNl84bU9aUHZ1ZFJVUC1DZw?oc=5", "source_name": "Market source", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies (OSUR) director buys 75,000 shares in market trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQc21tbkFpZkZXQ0NUUnRKLTZPUkVLOWFJaHBjZXhsSFJ0V2tCbmtXRkdHUzVta2xtakEwcXB5eVVZUFBOTkYwMHNVd0lIbGFUa3BpZENVclNXenltNVhaM2ZfT0dIVUVrMHo0Wkp0akgtcVNpYmh4TzZLbEpXSHRwUHhlZTBMUmxwdWZWSkF2bWZYMGMzNXk3ZmNuZTNfT1N2VWlqOWtselpocG9xQnppa1gyNGpmTkpJR0E?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure director Steven Boyd purchases $224,750 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxORndiUzM3YU1LZkp6WDBLZFpqbkYzaFVWVlJ5Rjk4SDQzZVotdlFJQUFBcGxRdDEzcGNfZlpUMzVHdHhxNHVhdTRZb2pyX2hLcWgyYzBJODRrUVpwbms3U1BHZk13dkdzQXhXVDBvLVpTQWE3M2x2TUFzVHdQd1BKbHVuWlRlT0NENS12Y0EzQjUtVHFKOENWM1BrTVB0YzVRbThxamdwNUlrclZ3UFZ1MUsxT21PRnhZNkVn?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/2d8c17e4-439d-3096-a9ed-621227ab7a82/orasure-technologies%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-07T12:30:00+00:00", "published_display": "07 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/27cb5c03-d8df-31b9-98b8-d095fda665ca/orasure-technologies-q1.html", "source_name": "MarketBeat", "published_at": "2026-05-07T03:06:38+00:00", "published_display": "07 May 2026 03:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure (OSUR) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/00baaff7-6020-3afa-b23e-986e07384ef9/orasure-%28osur%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-06T22:47:39+00:00", "published_display": "06 May 2026 22:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/orasure-q1-earnings-snapshot-213307242.html", "source_name": "Associated Press", "published_at": "2026-05-06T21:33:07+00:00", "published_display": "06 May 2026 21:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Announces First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNeGNwMzFqOWphWU5ncVpLSkc3VXVUXzhVYk4zUndnV1JCaG1hYTcyakUxWGpCR3Q5V2hHWTYwV1RydXU0VzFLdThCXzdrM0JrRDEyU1BQOEJwWWpXZUdyUUVyVGNjZ1RmZjdwbmx0MS1Vc0FJWDgxemhpaXQ1WmNBOEg3RWM0d29XLVRCSGZWQ2FYUl9BV2Q4LWMzU0RWSFdUYkZGS0JvMlZtQjV1MllmN25OaE1zaVVscnBMVUM5b2tMVlpG?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why OraSure Technologies (OSUR) Is Back in the Spotlight as Sale Pressure Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNelRtekF3N2Jad09GVnMtMnh4V0E3bUVpdXoyZ1RXMEQ1dVNaX1VZLTZPZ2k3NHpyckNFVHhzM3ljZXpkWkJxSTFGU05aUnl6VjVYSDFOaVJYbGVGNTcybmlzdXR4UXYtY0VfdkVEdVB4TXJFUWt4RmlvLXRab3hidlRGVXhYcExCNG9wZU9zYXpFZm1tMF8xbndtbDd0QlFt?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Altai Capital presses OraSure to sell and give it board seats, letter says", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNOWk4TEd4ZTRKcHhVZUE3NkFiNEFiUnNlek5kOWJ2V0tnbUpGc1pJcnhnNG4zQXFSR25Oam5FNnBFMUtVbUhsRE1aNFBBS1lLOG1uSFVYLS1nNGZ2YzN2Ym1HMWp4a1JIN1Y0T3NSTFNZZlIwbzJtZERxSjMtcGFLcFJVTVBZTG41R3M4QmlKUXhDcnlhbUliTktic2VIX0lmamlfSHdvOVhuOHRpQlFRdTFycERQUVZ4bTg1TmhDSkt1eTZlQnhpOW1LSEpqcTQ3MVZ6aEZtVlhTMGNSdjJOYQ?oc=5", "source_name": "Reuters", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Former VA head departs OraSure board", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOd0Z1a1RfakpCSXJwUDBkeW1neEo0X24xY0ZqTU9FWEtYbDFWNWduU1JjNnpMR013OE5sc1ZUc19jZ2YxeDlpd1JreW9VazVpZF9Bc3M1YTdBMV9kWHo4Yy1yZHUwOGdZVE5IMU5HczJPcFNBR05pTVNVWGhwbk1lY1dITmlXQU5zeFE2ZEdEZnlxZlNqazVvcEFFOWo0SDBTTGtpeW1BalhzUldDbkxqWlA2cGxMc0JOWVViRnhHT2JfWUZoRHJweVBn?oc=5", "source_name": "WFMZ.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Altai Capital lays groundwork for board fight at OraSure Technologies, sources say", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPQWlwakRvRmh0cTJHRXQybFhGQjd1SmRyMkF1bUYxMWhTT0RxRlhXbXVXS1hRd3Z4Q1NYQkJiWHh6MUl1c0FkNzMxQzNtbUZya0hqQjkwNXF4bkF2UTdUMnE2X1Z1S01SQUh1TjYyQWxqQkdrWU94cElBSkZGUzZ1eENvZjhIYnNJaTBXYjluN1gycDhTUmxXWUFwQTZQa0toQU96eXhlMlNLWG5ZaHFoaTM1LWNmZ2pFR3VROWpBeXNkMUdLNTFDQlRn?oc=5", "source_name": "Reuters", "published_at": "2025-09-09T07:00:00+00:00", "published_display": "09 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOemdiR1d1UEhMNE1DNzhmNVBpVlA3N2loQVg5dUFQaG5QNGtvSjk5MWdtZzNoWDJRTnIxRlhqZ3hXWkNHbl9RZHBlQTJqYTd4S2RoOG1EVlNLRnhRQ2kwOEFCMGs5S0lHZnRwcVVna0JoY3lHNlZEb3pHampmcHR3M2NfTDREd0VpOEUwYWRpSjI5bnJHMG5laXdadk9UNEcycUhtVWJFalltYjJOUkJyYWthdVh3VkQwX2FuTzduYURJaWJTSWtxSlJGaUxoOW01MWx6VnJiNEpZRXQ5WjZvVEg2RQ?oc=5", "source_name": "Reuters", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies, Inc. (NASDAQ:OSUR) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-08T07:00:00+00:00", "published_display": "08 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies received takeover bid from industry entrepreneur, sources say", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOVDY2eFJ1aER0SExrMllzOWJMS0ZUbXExSktkVEt6a3M0WmtGMW51U1psbWtsWE8zNGpFbWFhcjFfTzJ3MEhLSWs0N25Zb2swb0g0TThRUHNHM0RZRzV1c3FEc0lEZU9RNENoYkhKVjNPX1N2TXJBaUxld0NQdGUtUC0zdE0yQUJrdWJMeHdwaFNqeF83c2ZTV0s1Wk1MOE1DLWFpOWYxUVF2LXFFWmRkWGZaY0lYNkhGQzRpa0NFQkFLQ2hiM3BHSEhlZTc?oc=5", "source_name": "Reuters", "published_at": "2025-07-14T07:00:00+00:00", "published_display": "14 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orasure Tech (OSUR) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE4xejlIeUFnTThER0ZZbmZDX2Q0RWRiVjZlVDdVanViQjlfbFJnb3ZyeWd1eXBadU1pdjFJejZrRTBiSzRnSmkzdi1BMElOT1V5MWVr?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:31:43+00:00", "published_display": "25 Apr 2025 01:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OraSure Technologies - OSUR - Stock Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE53dHZ5RlpxRHViLXhmQkdaZFRFdU1XMmg2Y25tRktUWDZvTHZHdDhrWWJVRmljNGVfb1lINGItNndETUhmVzl2MDJwMzBUck11?oc=5", "source_name": "The Motley Fool", "published_at": "2021-09-15T20:40:07+00:00", "published_display": "15 Sep 2021 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 84, "total_relevant": 49, "sentiment_summary": {"positive": 15, "negative": 3, "neutral": 31, "score": 56, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 20.1, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 6.95, "count": 12}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 4.29, "latest_week": "2026-07-10", "one_week_move": -1.3, "four_week_move": 2.8, "twelve_week_move": 35.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.186702, "market_dynamics_buy_signal": false, "relative_strength": 20.446206, "fair_value_gap": 0.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 34.7448, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.3% over one week, +2.8% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 7}, {"label": "Stock Titan", "count": 5}, {"label": "dars.gov.et", "count": 4}, {"label": "TradingKey", "count": 4}, {"label": "Reuters", "count": 4}, {"label": "Investing.com", "count": 3}, {"label": "Ad-hoc-news.de", "count": 2}, {"label": "Donan\u0131mHaber", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 12}, {"label": "Macro sensitivity", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.3% over one week, +2.8% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "OraSure Technologies stock holds steady as diagnostics business targets growth"}], "updated_at": "2026-07-16T07:04:04.335458+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}